![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 1, 114-122, April 2003
University of Leipzig, Heart Centre Leipzig, Clinic for Cardiac
Surgery, Leipzig, Germany
Diabetes mellitus often leads to generalized vasculopathy. Because of
the pathophysiological role of free radicals we investigated the
effects of vitamin E. Twenty-eight rats were rendered diabetic by
streptozotocin injection and were fed either with a diet with low (10 mg/kg of chow), medium (75 mg/kg of chow) or high amounts of vitamin E
(1300 mg/kg of chow). Nine age-matched nondiabetic rats receiving 75 mg
of vitamin E/kg chow served as controls. After 7 months, mesenteric
microcirculation was investigated. Smooth muscle contractile function
was not altered in diabetic versus nondiabetic vessels. Endothelial
function was significantly reduced in diabetics; relaxation upon 1 µM
acetylcholine was reduced by 50% in diabetics with a medium and high
vitamin E diet. In vitamin E-deprived rats, a complete loss of
endothelium-dependent relaxation was observed, and instead,
acetylcholine elicited vasoconstriction. L-NG-Nitro-arginine-induced
vasoconstriction was reduced in small arteries in diabetics, which was
not prevented by vitamin E, but was aggravated by vitamin E
deprivation. In a subchronic endothelial cell culture model, cells were
cultivated with 5 or 20 mM D-glucose for an entire cell
culture passage (4 days) with or without vitamin E (20 mg/l versus 0.01 mg/l). Hyperglycemia led to significant reduction in basal and
ATP-stimulated nitric oxide (NO)-production. Hyperglycemia-induced
reduction in basal NO-release was significantly prevented by vitamin E,
whereas reduction in stimulated NO-release was not influenced.
NADPH-diaphorase activity was reduced by 40% by hyperglycemia, which
was completely prevented by vitamin E. We conclude that 1) vitamin E
has a potential to prevent partially hyperglycemia-induced endothelial
dysfunction, 2) under in vivo conditions vitamin E deficiency enhanced
diabetic endothelial dysfunction dramatically, and 3) positive effects
of vitamin E may be attenuated with a longer disease duration.
This article has been cited by other articles:
![]() |
M. Niehof and J. Borlak HNF4{alpha} and the Ca-Channel TRPC1 Are Novel Disease Candidate Genes in Diabetic Nephropathy Diabetes, April 1, 2008; 57(4): 1069 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Niehof and J. Borlak RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain Mol. Pharmacol., March 1, 2005; 67(3): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Manzella, R. Grella, A. M. Abbatecola, and G. Paolisso Repaglinide Administration Improves Brachial Reactivity in Type 2 Diabetic Patients Diabetes Care, February 1, 2005; 28(2): 366 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kabat, K. Ponicke, A. Salameh, F.-W. Mohr, and S. Dhein Effect of a {beta}2-Adrenoceptor Stimulation on Hyperglycemia-Induced Endothelial Dysfunction J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 564 - 573. [Abstract] [Full Text] [PDF] |
||||